Exécution de notre outil de synthèse sur un nouvel article
Vérifiez l’article ci-dessous, puis lancez sa synthèse.
The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease
Inmaculada Sanjuan-Ruiz (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Lutgarde Serneels (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Katleen Craessaerts (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Alison Goate (Icahn School of Medicine at Mount Sinai), Wim G. Annaert (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Lucía Chávez‐Gutiérrez (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Yonggang Shi (University of Southern California), Nasim Sheikh‐Bahaei (University of Southern California), Joanna C. Jen (University of California, Los Angeles), Eliana Marisa Ramos (University of California, Los Angeles), Mihaela Campan (University of Southern California, Keck Hospital of USC), Pamela Ward (University of Southern California, Keck Hospital of USC), Shino Magaki (University of California, Los Angeles), Kelly Bartlone (University of California, Los Angeles), Harry V. Vinters (University of California, Los Angeles), the Dominantly Inherited Alzheimer Network (City of Hope, Beckman Research Institute), David Wesley Craig (City of Hope, Beckman Research Institute), John Matthew Ringman (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research), Bart De Strooper (Vlaams Instituut voor Biotechnologie, VIB-KU Leuven Center for Brain & Disease Research)
Résumé : Over 300 mutations in PSEN1 have been identified as causes of early-onset Alzheimer’s disease (EOAD). While these include missense mutations and a few insertions, deletions, or duplications, none result in open reading frame shifts, and all alter γ-secretase function to increase the long/short Aβ ratio. We identified a novel heterozygous PSEN1 nonsense variant, c.325A > T, in a patient and his father, both presenting with EOAD, resulting in the substitution of lysine 109 with a premature stop codon at position (p.K109*). This produces a truncated 109 amino acid (aa) N-terminal PSEN1 fragment. Functional characterization was performed using overexpression models and a heterozygous mouse model (Psen1 K109*/+ ). In overexpression models, downstream ATGs serve as alternative starting codons, generating a > 37 kDa and a > 27 kDa PSEN1 C-terminal fragment (PSEN1-CTF A and PSEN1-CTF B , respectively) that retain the two catalytic aspartates of γ-secretase. Heterozygous Psen1 K109*/+ mice exhibited subtle phenotypic defects, including reduced Pen2 expression and mild APP-CTF accumulation. Notably, aged mice demonstrated significantly increased Psen2 protein expression, potentially contributing to an elevated Aβ42/Aβ38 ratio. These findings indicate that PSEN1 c.325A > T (p.K109*) is not a complete loss-of-function mutation. However, to what extent and by what mechanism it contributes to EOAD pathogenesis remains unclear.